Login / Signup

Association of Valproic Acid Use With Post-Myocardial Infarction Heart Failure Development: A Meta-Analysis of Two Retrospective Case-Control Studies.

Joseph D EnglishShuo TianZhong WangJasmine A Luzum
Published in: Journal of cardiovascular pharmacology and therapeutics (2022)
VPA doses ≥1000 mg/day may provide post-MI cardio-protection resulting in a reduced incidence of HF.
Keyphrases
  • case control
  • heart failure
  • left ventricular
  • acute heart failure
  • risk factors
  • atrial fibrillation